Five-year experience of organized colorectal cancer screening in a Swedish population - increased compliance with age, female gender, and subsequent screening round

Journal of Medical Screening

Volumn 21, Issue 3, 2014, Pages 144-150

  Blom, Johannes ^a   Kilpeläinen, Sini ^b   Hultcrantz, Rolf ^a   Törnberg, Sven ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Stockholm Gotland Regional Cancer Centre   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Colorectal; Compliance; FOBT; Neoplasm; Population; Screening

Indexed keywords

AGED; ARTICLE; COLONOSCOPY; COLORECTAL; COLORECTAL TUMOR; COMPLIANCE (PHYSICAL); EARLY DIAGNOSIS; FEMALE; FOBT; HUMAN; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASM; OCCULT BLOOD; PATIENT COMPLIANCE; POPULATION; SCREENING; STATISTICS; SWEDEN;

COLORECTAL; COMPLIANCE; FOBT; NEOPLASM; POPULATION; SCREENING;

AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PATIENT COMPLIANCE; SWEDEN;

EID: 84908482022     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1177/0969141314545555     Document Type: Article

References (31)

1. Soerjomataram I, Lortet-Tieulent J, Parkin DM, Ferlay J, Mathers C, Forman D, et al. Global burden of cancer in 2008: a systematic analysis of disability-adjusted lifeyears in 12 world regions. Lancet. 2012 Nov 24; 380(9856): 1840–50. PubMed PMID: 23079588.
2. Wilson JMG, Jungner G. Principles and practice of screening for disease. WHO Public Health Papers 1968; 34: 1–163.
3. Winawer SJ, Zauber AG, Ho MN, O’Brien MJ, Gottlieb LS, Sternberg SS, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993 Dec 30; 329(27): 1977–81. PubMed PMID: 8247072.
4. Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med. 1995 Dec 15; 123(12): 904–10. PubMed PMID: 7486484.
5. Thiis-Evensen E, Hoff GS, Sauar J, Langmark F, Majak BM, Vatn MH. Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand J Gastroenterol. 1999 Apr; 34(4): 414–20. PubMed PMID: 10365903.
6. Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010 May 8; 375(9726): 1624–33. PubMed PMID: 20430429.
7. Segnan N, Armaroli P, Bonelli L, Risio M, Sciallero S, Zappa M, et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial–SCORE. J Natl Cancer Inst. 2011 Sep 7; 103(17): 1310–22. PubMed PMID: 21852264.
8. Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 2012 Jun 21; 366(25): 2345–57. PubMed PMID: 22612596. PubMed Central PMCID: 3641846.
9. The Council of the European Union (2003/878/EC). Council Recommendation of 2 December 2003 on cancer screening. Official Journal of the European Union Dec 2003; 16: 34–9.
10. Zavoral M, Suchanek S, Zavada F, Dusek L, Muzik J, Seifert B, et al. Colorectal cancer screening in Europe. World J Gastroenterol. 2009 Dec 21; 15(47): 5907–15. PubMed PMID: 20014454. PubMed Central PMCID: 2795177.
11. Zorzi M, Barca A, Falcini F, Grazzini G, Pizzuti R, Ravaioli A, et al. Screening for colorectal cancer in Italy: 2005 survey. Epidemiol Prev. 2007 Mar-Jun; 31(2–3 Suppl 2):49–60. PubMed PMID: 17824362.
12. Rees CJ, Bevan R. The National Health Service Bowel Cancer Screening Program: the early years. Expert review of gastroenterology & hepatology. 2013 Jul; 7(5): 421–37. PubMed PMID: 23899282.
13. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996 Nov 30; 348(9040): 1472–7. PubMed PMID: 8942775.
14. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996 Nov 30; 348(9040): 1467–71. PubMed PMID: 8942774.
15. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst. 1999 Mar 3; 91(5): 434–7. PubMed PMID: 10070942.
16. European Colorectal Cancer Screening Guidelines Working G, von Karsa L, Patnick J, Segnan N, Atkin W, Halloran S, et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy. 2013; 45(1): 51–9. PubMed PMID: 23212726.
17. Malila N, Oivanen T, Hakama M. Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme. Z Gastroenterol. 2008 Apr; 46 Suppl 1:S25–8. PubMed PMID: 18368636.
18. Swedish Tax Agency. Register of the total population. Stockholm, Sweden. Available from: http://www.skatteverket.se/download/18.2b543913a42158acf80003761/1386594730871/Allm%C3%A4nBeskrivning.pdf (accessed December 2013).
19. Barlow L, Westergren K, Holmberg L, Talback M. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol. 2009; 48(1): 27–33. PubMed PMID: 18767000.
20. National Board of Health and Welfare. Cancer Register [cited 2013 December]. Stockholm, Sweden. Available from: http://www.socialstyrelsen.se/register/halsodataregister/cancerregistret/inenglish (accessed December 2013).
21. Rex DK, Petrini JL, Baron TH, Chak A, Cohen J, Deal SE, et al. Quality indicators for colonoscopy. Am J Gastroenterol. 2006 Apr; 101(4): 873–85. PubMed PMID: 16635231.
22. Kaminski MF, Regula J, Kraszewska E, Polkowski M, Wojciechowska U, Didkowska J, et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med. 2010 May 13; 362(19): 1795–803. PubMed PMID: 20463339.
23. Paimela H, Malila N, Palva T, Hakulinen T, Vertio H, Jarvinen H. Early detection of colorectal cancer with faecal occult blood test screening. Br J Surg. 2010 Oct; 97(10): 1567–71. PubMed PMID: 20603855.
24. Lee TJ, Blanks RG, Rees CJ, Wright KC, Nickerson C, Moss SM, et al. Longer mean colonoscopy withdrawal time is associated with increased adenoma detection: evidence from the Bowel Cancer Screening Programme in England. Endoscopy. 2013; 45(1): 20–6. PubMed PMID: 23254403.
25. Rabeneck L, Tinmouth JM, Paszat LF, Baxter NN, Marrett LD, Ruco A, et al. Ontario’s ColonCancerCheck: Results from Canada’s First Province-Wide Colorectal Cancer Screening Program. Cancer Epidemiol Biomarkers Prev. 2014 Mar; 23(3): 508–15. PubMed PMID: 24443406.
26. Goulard H, Boussac-Zarebska M, Ancelle-Park R, Bloch J. French colorectal cancer screening pilot programme: results of the first round. J Med Screen. 2008; 15(3): 143–8. PubMed PMID: 18927097.
27. Kershenbaum A, Flugelman A, Lejbkowicz F, Arad H, Rennert G. Excellent performance of Hemoccult Sensa in organised colorectal cancer screening. Eur J Cancer. 2013 Mar; 49(4): 923–30. PubMed PMID: 23099005.
28. Bulliard JL, Garcia M, Blom J, Senore C, Mai V, Klabunde C. Sorting out measures and definitions of screening participation to improve comparability: The example of colorectal cancer. Eur J Cancer Jan 2014; 50(2): 434–46. PubMed PMID: 24144735.
29. Faivre J, Bouvier AM, Bonithon-Kopp C. Epidemiology and screening of colorectal cancer. Best Pract Res Clin Gastroenterol. 2002 Apr; 16(2): 187–99. PubMed PMID: 11969233.
30. Ramji F, Cotterchio M, Manno M, Rabeneck L, Gallinger S. Association between subject factors and colorectal cancer screening participation in Ontario, Canada. Cancer Detect Prev. 2005; 29(3): 221–6. PubMed PMID: 15896925.
31. Kronborg O, Jorgensen OD, Fenger C, Rasmussen M. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scand J Gastroenterol. 2004 Sep; 39(9): 846–51. PubMed PMID: 15513382.